IFITM2 Polyclonal antibody 12769-1-AP proteintech

$149.00
In stock
SKU
12769-1-AP
Catalog No.SizePrice (USD)
12769-1-AP-20UL20 μL$149.00
12769-1-AP-150UL150 μL$449.00
Catalog Number12769-1-AP
Synonyms1 8D, 18D, DSPA2c, IFITM 2, Interferon-induced transmembrane protein 2
HostRabbit
Reactivityhuman, mouse and More (2)
Reactivityhuman, mouse, rat, pig
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, IP, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inA549 cells, HepG2 cells, SKOV-3 cells, MCF-7 cells
Tested Applications — Positive IP detected inHepG2 cells
Tested Applications — Positive IHC detected inhuman breast cancer tissue, mouse brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inHeLa cells
Recommended Dilutions — Western Blot (WB)WB : 1:2000-1:10000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:20-1:200
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:250-1:1000
Positive WB detected inA549 cells, HepG2 cells, SKOV-3 cells, MCF-7 cells
Positive IP detected inHepG2 cells
Positive IHC detected inhuman breast cancer tissue, mouse brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells
Western Blot (WB)WB : 1:2000-1:10000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)/ICCIF/ICC : 1:250-1:1000
Tested Reactivityhuman, mouse
Cited Reactivityhuman, mouse, rat, pig
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag3451 Product name: Recombinant human IFITM2 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-132 aa of BC009696 Sequence: MNHIVQTFSPVNSGQPPNYEMLKEEQEVAMLGAPHNPAPPTSTVIHIRSETSVPDHVVWSLFNTLFMNTCCLGFIAFAYSVKSRDRKMVGDVTGAQAYASTAKCLNIWALILGIFMTILLVIIPVLVVQAQR Predict reactive species
Full Nameinterferon induced transmembrane protein 2 (1-8D)
Calculated Molecular Weight132 aa, 15 kDa
Observed Molecular Weight15-17 kDa
GenBank Accession NumberBC009696
Gene SymbolIFITM2
Gene ID (NCBI)10581
RRIDAB_2122089
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDQ01629
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for IFITM2 antibody 12769-1-APDownload protocol
IHC protocol for IFITM2 antibody 12769-1-APDownload protocol
IP protocol for IFITM2 antibody 12769-1-APDownload protocol
WB protocol for IFITM2 antibody 12769-1-APDownload protocol
humanWB Nat Commun IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses Authors - M. Clement View Article
Citations50
DilutionsWB : 1:2000-1:10000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC : 1:20-1:200 IF/ICC : 1:250-1:1000
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

IFITM2, also named as 1-8D, belongs to the CD225 family. It is an IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus , by inhibiting the early steps of replication. IFITM2 induces cell cycle arrest and mediates apoptosis by caspase activation and in p53-independent manner. It is overexpressed in colon carcinoma. IFITM2 is a novel pro-apoptotic gene that will provide new insights into the regulated cellular pathways to death. IFITM proteins are recently identified as viral restriction factors that inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. Also they serve as important components of the innate immune system to restrict HIV-1 infection. Catalog#12769-1-AP is a rabbit polyclonal antibody produced with full-length of human IFITM2. Protocols Product Specific Protocols IF protocol for IFITM2 antibody 12769-1-AP Download protocol IHC protocol for IFITM2 antibody 12769-1-AP Download protocol IP protocol for IFITM2 antibody 12769-1-AP Download protocol WB protocol for IFITM2 antibody 12769-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
    Journal: Cell | Authors: Abraham L Brass | Species: human | Application: WB
  2. PMID: 30416070
    Journal: Cell Stem Cell | Authors: Carolina Petrillo | Species: human | Application: WB
  3. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
    Journal: Cell Host Microbe | Authors: Toshana L Foster KD Validated | Species: human | Application: WB
  4. IFITM2 Modulates Endocytosis Maintaining Neural Stem Cells in Developing Neocortex
    Journal: Adv Sci (Weinh) | Authors: Yuqing Lv | Species: human | Application: IF
  5. IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread.
    Journal: Cell Host Microbe | Authors: Alex A Compton KD Validated | Species: human | Application: WB,FC
  6. IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses
    Journal: Nat Commun | Authors: M. Clement | Species: human | Application: WB
  7. IFITMs mediate viral evasion in acute and chronic hepatitis C virus infection.
    Journal: Hepatology | Authors: Florian Wrensch | Species: human | Application: WB,IF
  8. Simulated microgravity induces cerebral dysfunction by disturbing protective microbiota-metabolite-microglia signaling across the gut‒brain axis.
    Journal: Gut Microbes | Authors: Biying Zhang | Species: rat | Application: WB
  9. IFITM2 Modulates Endocytosis Maintaining Neural Stem Cells in Developing Neocortex
    Journal: Adv Sci (Weinh) | Authors: Yuqing Lv | Species: human | Application: IF
  10. Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy.
    Journal: Cell Rep Med | Authors: Po-Hsien Chiu | Species: human | Application: WB
  11. Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunity
    Journal: EMBO J | Authors: Giulia Unali | Species: human | Application: WB,IF
  12. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
    Journal: Cell Rep | Authors: Jingyou Yu | Species: human | Application: WB
  13. BAG3(+) CAF-T cell neighborhood predicts resistance to neoadjuvant chemoimmunotherapy in NSCLC.
    Journal: Front Immunol | Authors: Jing Sun
  14. Swine Interferon-Inducible Transmembrane Proteins Potently Inhibit African Swine Fever Virus Replication.
    Journal: Front Immunol | Authors: Siqi Cai | Application: WB
  15. Identifying key barriers in cationic polymer gene delivery to human T cells
    Journal: Biomater Sci | Authors: Brynn R. Olden | Species: human | Application: WB
  16. Inhibition of Arenavirus Entry and Replication by the Cell-Intrinsic Restriction Factor ZMPSTE24 Is Enhanced by IFITM Antiviral Activity.
    Journal: Front Microbiol | Authors: Robert J Stott-Marshall | Species: human | Application: WB,IP
  17. Interferon-Induced Transmembrane Proteins Inhibit Infection by the Kaposi's Sarcoma-Associated Herpesvirus and the Related Rhesus Monkey Rhadinovirus in a Cell-Specific Manner.
    Journal: mBio | Authors: Bojan F Hörnich | Species: human | Application: IF
  18. IFITM proteins restrict viral membrane hemifusion.
    Journal: PLoS Pathog | Authors: Li Kun K | Species: human
  19. IFITM proteins restrict viral membrane hemifusion.
    Journal: PLoS Pathog | Authors: Li Kun K | Species: human
  20. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
    Journal: PLoS Pathog | Authors: I-Chueh Huang | Species: human | Application: WB
  21. IFITM1 enhances nonenveloped viral RNA replication by facilitating cholesterol transport to the Golgi
    Journal: PLoS Pathog | Authors: Kumiko Ishikawa-Sasaki | Species: human | Application: WB,IF
  22. Contribution of endosomal proteins EHD1 and EHD4 to the HIV-1 replication cycle.
    Journal: FEBS J | Authors: Grégory Pacini | Species: human | Application: WB
  23. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
    Journal: Retrovirology | Authors: Kevin Tartour | Species: human | Application: WB
  24. The IFITM proteins inhibit HIV-1 infection.
    Journal: J Virol | Authors: Lu Jennifer J | Species: human | Application: WB
  25. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.
    Journal: J Virol | Authors: Jiang Dong D | Species: human | Application: WB
  26. The role of MxB in interferon-α mediated inhibition of HIV-1 infection.
    Journal: J Virol | Authors: Bin Xu | Species: human | Application: WB
  27. The zinc metalloprotease ZMPSTE24 binds a distinct topological isoform of the tail-anchored protein IFITM3.
    Journal: J Biol Chem | Authors: Eric D. Spear
  28. pH-optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza A viruses to the interferon-induced antiviral state and IFITMs.
    Journal: J Virol | Authors: Thomas Gerlach | Species: human
  29. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
    Journal: Retrovirology | Authors: Kevin Tartour | Species: human | Application: WB
  30. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
    Journal: J Infect Dis | Authors: Florian Wrensch | Species: human | Application: WB
  31. Contrasting interferon-mediated antiviral responses in human lung adenocarcinoma cells
    Journal: J Virol | Authors: Matthew Esparza | Species: human | Application: WB
  32. IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus.
    Journal: J Virol | Authors: Mudhasani Rajini R | Species: human | Application: WB,IF
  33. The role of MxB in interferon-α mediated inhibition of HIV-1 infection.
    Journal: J Virol | Authors: Bin Xu | Species: human | Application: WB
  34. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
    Journal: J Virol | Authors: Bertram Stephanie S
  35. IFITM2 Presents Antiviral Response through Enhancing Type I IFN Signaling Pathway
    Journal: Viruses | Authors: Lei Chen | Species: human | Application: WB
  36. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
    Journal: Viruses | Authors: Jingyou Yu | Species: human | Application: WB
  37. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
    Journal: Viruses | Authors: Jingyou Yu | Species: human | Application: WB
  38. IFITM2 Presents Antiviral Response through Enhancing Type I IFN Signaling Pathway
    Journal: Viruses | Authors: Lei Chen | Species: human | Application: WB
  39. IFITM proteins inhibit the late step of feline foamy virus replication.
    Journal: Anim Cells Syst (Seoul) | Authors: Jinsun Kim | Species: human | Application: WB
  40. Differential restriction of chikungunya virus in primary human cardiac endothelial cells occurs at multiple steps in the viral life cycle
    Journal: PLoS Negl Trop Dis | Authors: Sophie N Spector | Species: human | Application: WB
  41. Host antiviral protein IFITM2 restricts pseudorabies virus replication.
    Journal: Virus Res | Authors: Jingying Xie | Species: pig | Application: WB
  42. TLR-mediated aggresome-like induced structures comprise antimicrobial peptides and attenuate intracellular bacterial survival
    Journal: Mol Biol Cell | Authors: Anushree Bhatnagar | Species: human | Application: WB,IF
  43. IFITM proteins restrict antibody-dependent enhancement of dengue virus infection.
    Journal: PLoS One | Authors: Chan Ying Kai YK | Species: human | Application: WB
  44. Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection.
    Journal: PLoS One | Authors: Raquel Muñoz-Moreno | Species: human | Application: WB,IF
  45. Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques.
    Journal: PLoS One | Authors: Michael Winkler | Species: human | Application: WB
  46. Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins.
    Journal: Virology | Authors: Jin Qian | Species: human | Application: WB
  47. IFN-γ Triggered IFITM2 Expression to Induce Malignant Phenotype in Elderly GBM
    Journal: J Mol Neurosci | Authors: Tingyu Liang | Species: human | Application: IHC
  48. Differential restriction of chikungunya virus in primary human cardiac endothelial cells occurs at multiple steps in the viral life cycle
    Journal: bioRxiv | Authors: Sophie N Spector | Species: human | Application: WB
  49. The zinc metalloprotease ZMPSTE24 binds a distinct topological isoform of the tail-anchored protein IFITM3.
    Journal: bioRxiv | Authors: Eric D. Spear | Species: human | Application: WB
  50. Opposing activities of IFITM proteins in SARS-CoV-2 infection.
    Journal: bioRxiv | Authors: Guoli Shi | Species: human

Reviews

Write Your Own Review
You're reviewing:IFITM2 Polyclonal antibody 12769-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.